34-20E-21. Report on monitoring and use of prescription opioids.
The board shall, before the fourth Tuesday in January of each year, report to the Senate and House standing committees on health and human services on the monitoring and use of prescription opioids. This report shall include the number of opioid prescriptions from the prior three years. The report shall also include an update to any changes or advances made to the prescription drug monitoring program. (This section is repealed effective June 30, 2022 pursuant to SL 2017, ch 158, §2.)
Source: SL 2017, ch 158, §1.